ANIP

ANI Pharmaceuticals, Inc. · NASDAQ

Sector Health Technology
Industry Biotechnology
Website anipharmaceuticals.com
Employees(FY) 600
ISIN US00182C1036

Performance

-5.68%

-4.2%

-11.64%

-12.17%

-3.25%

YTD

+1.95%

Profile

ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations, including extended release and combination products. The company manufactures oral solid dose products; semi-solids, liquids, and topicals; and potent products, as well as performs contract development and manufacturing of pharmaceutical products. It markets its products through retail pharmacy chains, wholesalers, distributors and mail order pharmacies, and group purchasing organizations. ANI Pharmaceuticals, Inc. was incorporated in 2001 and is headquartered in Baudette, Minnesota.

Advanced Technical Analysis

Technical Analysis of ANIP 2024-12-20

The stock indicators reflect a bearish sentiment overall, with a Moving Average Score of 10 indicating strong downward momentum, an Oscillators Score of 43 suggesting a neutral stance, and a Technical Score of 26 reinforcing the bearish outlook. This combination signals caution for potential investors, as the prevailing trend appears to be negat...

Technical Scores and Rating

Moving Average Score

Oscillator Score

Technical Rating

Stock Analysis of ANIP

Stock Rank

Recent News & Updates

2024-12-18 18:02
Ani Pharmaceuticals Insider Sold Shares Worth $418,425, According to a Recent SEC Filing(MT Newswires)
2024-12-18 09:40
Should Value Investors Buy ANI Pharmaceuticals (ANIP) Stock?(Zacks)
2024-12-17 19:00
ANIP: Lowering target price to $59.00(Argus Research)
2024-12-11 07:59
Leerink Partners Initiates ANI Pharmaceuticals at Outperform With $80 Price Target(MT Newswires)
2024-12-10 19:00
ANIP: Raising target price to $62.00(Argus Research)
2024-12-06 09:40
Are Medical Stocks Lagging Adagene (ADAG) This Year?(Zacks)
2024-12-03 19:00
ANIP: Lowering target price to $60.00(Argus Research)
2024-12-02 14:21
Should Value Investors Buy ANI Pharmaceuticals (ANIP) Stock?(Zacks)
2024-11-29 03:32
Ani Pharmaceuticals Insider Sold Shares Worth $1,941,442, According to a Recent SEC Filing(MT Newswires)
2024-11-26 19:00
ANIP: Raising target price to $61.00(Argus Research)
2024-11-26 16:30
ANI Pharmaceuticals to Present at 36th Annual Piper Sandler Healthcare Conference(GlobeNewswire)
2024-11-26 09:55
Does ANI (ANIP) Have the Potential to Rally 31.31% as Wall Street Analysts Expect?(Zacks)
2024-11-26 03:30
ANI Pharmaceuticals to Present at 36th Annual Piper Sandler Healthcare Conference(Globenewswire)
2024-11-20 12:00
ANI (ANIP) Upgraded to Buy: What Does It Mean for the Stock?(Zacks)
2024-11-20 09:40
Is Adagene (ADAG) Stock Outpacing Its Medical Peers This Year?(Zacks)
2024-11-18 16:08
Ani Pharmaceuticals Insider Sold Shares Worth $375,050, According to a Recent SEC Filing(MT Newswires)
2024-11-14 09:40
Are Investors Undervaluing ANI Pharmaceuticals (ANIP) Right Now?(Zacks)
2024-11-12 19:00
ANIP: Raising target price to $64.00(Argus Research)
2024-11-10 08:30
ANI Pharmaceuticals Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags(Simply Wall St.)
2024-11-09 04:00
ANI Pharmaceuticals Inc (ANIP) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and ...(GuruFocus.com)
2024-11-08 10:00
Compared to Estimates, ANI (ANIP) Q3 Earnings: A Look at Key Metrics(Zacks)
2024-11-08 08:05
ANI Pharmaceuticals (ANIP) Q3 Earnings and Revenues Surpass Estimates(Zacks)
2024-11-08 07:20
ANI Pharmaceuticals' Q3 Adjusted Earnings, Net Revenue Rise; Fiscal 2024 Outlook Lifted(MT Newswires)
2024-11-08 06:58
ANI: Q3 Earnings Snapshot(Associated Press Finance)
2024-11-08 06:50
ANI Pharmaceuticals Reports Record Third Quarter 2024 Financial Results and Raises 2024 Guidance(GlobeNewswire)
2024-11-07 19:21
ANI Pharma Boosts FY24 Outlook As Q3 Results Top Estimates - Update(Rttnews)
2024-11-07 17:50
ANI Pharmaceuticals Reports Record Third Quarter 2024 Financial Results and Raises 2024 Guidance(Globenewswire)
2024-11-07 07:06
ANI Pharmaceuticals Inc (ANIP) Q3 2024 Earnings Report Preview: What To Expect(GuruFocus.com)
2024-11-05 19:00
ANIP: Lowering target price to $60.00(Argus Research)
2024-11-04 16:30
ANI Pharmaceuticals to Present at Guggenheim's Inaugural Healthcare Innovation Conference and Jefferies London Healthcare Conference in November(GlobeNewswire)

Page 1 of 10

previousnext

Disclaimer: The information provided here and on kavout.com site is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout does not recommend that any investment decision be made based on this information. You are solely responsible for your own investment decisions. Please conduct your own research and consult with qualified financial advisors before making any investment. Kavout and its partners are participants in a number of affiliate advertising programs. As an Amazon Associate, Kavout or its partners earn from qualifying purchases from affiliate links. We also participate in other affiliate and advertising programs that provide a means for us to earn advertising fees by advertising and linking to third-party websites.